Peptide Per 5 Units (2mg blend) Per 10 Units (4mg blend) GHK-Cu 1.25 mg 2.50 mg KPV 250 mcg 500 mcg BPC-157 250 mcg 500 mcg TB-500 250 mcg 500 mcg At the 10-unit dose, all four components land within commonly cited research ranges: GHK-Cu at 2.5mg, and BPC-157, TB-500, and KPV each at 500mcg
First, BPC-157 is not FDA-approved as a drug, and it's not available as a standard commercial pharmaceutical
Generally, depression is becoming more common among adults in recent years
Substances under S2.2.3 are non-Specified Substances under the WADA Code
Regular Consultations: Consistent check-ups with a healthcare provider can help adjust your therapy as needed
The synergistic activation of these receptors through triple therapy leads to amplified effects on weight reduction, enhanced glycemic control, and improved lipid profiles across multiple tissues, including the pancreas, brain, liver, and adipose tissue